Race, Ethnicity Underreported in Early Phase Pediatric Cancer Trials
Race and ethnicity were reported in less than 25% of the trials studied.
Race and ethnicity were reported in less than 25% of the trials studied.
Cancer-specific mortality for HPV-related oropharyngeal cancer higher among non-Hispanic Black and Hispanic men than White men.
Disparities in cancer diagnoses among pediatric patients are partly a result of disparities in health insurance coverage, a study suggests.
For all stageable cancers combined, uninsured with stage I disease have worse survival than privately insured with stage II disease.
Researchers sought to determine whether the incidence of CAT was different across designated racial groups.
Invasive cancer detection rates, positive predictive values highest for non-Hispanic Whites, lowest for Hispanics.
At 10 years, the disease-free survival rate was 54.5%, and the overall survival rate was 50.7%.
An analysis sought to determine if risk measurements by the genetic signature would be similar for male patients with breast cancer to those of female patients with breast cancer.
Gap seen in cardiovascular, psychiatry, and cancer trial participation versus national prevalence disease data.
An analysis of published literature sought to measure the effects of social determinants of health on precision medicine for lung cancer in various racial and ethnic patient populations.